NCT00067327View on ClinicalTrials.gov

Treatment of Multiple Sclerosis Using Over the Counter Inosine

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

February 28, 2002

Study Completion Date

September 30, 2005

Conditions
Multiple Sclerosis, Relapsing-Remitting
Interventions
DRUG

Inosine

Trial Locations (1)

19104

Hospital of the University of Pennsylvania, Philadelphia

All Listed Sponsors
lead

National Center for Complementary and Integrative Health (NCCIH)

NIH

NCT00067327 - Treatment of Multiple Sclerosis Using Over the Counter Inosine | Biotech Hunter | Biotech Hunter